REGENERON PHARMACEUTICALS INC. - COMMON STOCK

Regeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare Delivery

13 1 2025 06:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

10 1 2025 12:29:29 提供 NetDania Notify

Regeneron to Report Fourth Quarter and Full Year 2024 Financial and Operating Results and Host Conference Call and Webcast on February 4, 2025

07 1 2025 16:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 12 2024 09:45:02 提供 NetDania Notify

Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept Results

19 12 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

18 12 2024 15:08:04 提供 NetDania Notify

Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

17 12 2024 16:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

17 12 2024 09:45:01 提供 NetDania Notify

EYLEA HD® (aflibercept) Injection 8 mg Phase 3 Trial Meets Primary Endpoint Showing Improved Vision with Extended Dosing Intervals in Patients with Macular Edema following Retinal Vein Occlusion

17 12 2024 07:00:00 提供 Nasdaq GlobeNewswire

Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year

16 12 2024 16:30:25 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 12 2024 09:45:56 提供 NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 12 2024 09:46:56 提供 NetDania Notify

Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of Treatment and Additional Types of Lymphoma

09 12 2024 17:45:23 提供 Nasdaq GlobeNewswire

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

07 12 2024 19:00:31 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 11 2024 10:19:05 提供 NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 11 2024 09:58:38 提供 NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 11 2024 10:06:22 提供 NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

18 11 2024 09:45:40 提供 NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 11 2024 09:45:06 提供 NetDania Notify

Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)

15 11 2024 00:59:51 提供 Nasdaq GlobeNewswire